Showing results (141-150 of 163) with videos related to
Sort By:
Pageof 17
Vaccine|March 24, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in AustraliaLucy Deng, Belinda Barton, Philip Choi, et al.Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational studyRoss I Baker, Grace Gilmore, Vivien Chen, et al.Urology|February 13, 2017
The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based CohortMaximilian F Lang, Mark D Tyson, JoAnn Rudd Alvarez, et al.The Journal of Urology|December 19, 2017
The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR StudySvetlana Avulova, Zhiguo Zhao, Daniel Lee, et al.BMJ Open|May 19, 2022
Guidance relevant to the reporting of health equity in observational research: a scoping review protocolAnita Rizvi, Daeria O Lawson, Taryn Young, et al.Molecular and Cellular Biology|February 3, 2016
Arrested Hematopoiesis and Vascular Relaxation Defects in Mice with a Mutation in DhfrJulie A I Thoms, Kathy Knezevic, Jia Jenny Liu, et al.Pathology|August 12, 2023
Looking beyond workforce parity: addressing gender inequity in pathologyCatriona A McKenzie, Ruta Gupta, Louise Jackett, et al.BMJ Open|March 12, 2024
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventionsJack Wilkinson, Calvin Heal, George A Antoniou, et al.Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventionsJack Wilkinson, Calvin Heal, George A Antoniou, et al.BMJ (Clinical Research Ed.)|April 14, 2025
CONSORT 2025 statement: updated guideline for reporting randomised trialsSally Hopewell, An-Wen Chan, Gary S Collins, et al.Pageof 17